| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| Domain | PP2A_PR55 | 1.25e-04 | 4 | 86 | 2 | IPR000009 | |
| Domain | MAGUK_N_PEST | 1.25e-04 | 4 | 86 | 2 | PF10608 | |
| Domain | PDZ_assoc | 1.25e-04 | 4 | 86 | 2 | PF10600 | |
| Domain | PP2A_PR55_CS | 1.25e-04 | 4 | 86 | 2 | IPR018067 | |
| Domain | DLG1_PEST_dom | 1.25e-04 | 4 | 86 | 2 | IPR019590 | |
| Domain | PDZ_assoc | 1.25e-04 | 4 | 86 | 2 | IPR019583 | |
| Domain | KN_motif | 1.25e-04 | 4 | 86 | 2 | IPR021939 | |
| Domain | MAGUK_N_PEST | 1.25e-04 | 4 | 86 | 2 | SM01277 | |
| Domain | DLG1 | 1.25e-04 | 4 | 86 | 2 | IPR016313 | |
| Domain | KN_motif | 1.25e-04 | 4 | 86 | 2 | PF12075 | |
| Domain | PR55_2 | 1.25e-04 | 4 | 86 | 2 | PS01025 | |
| Domain | PR55_1 | 1.25e-04 | 4 | 86 | 2 | PS01024 | |
| Domain | Pept_M16_Zn_BS | 4.34e-04 | 7 | 86 | 2 | IPR001431 | |
| Domain | Pept_M16_dom | 4.34e-04 | 7 | 86 | 2 | IPR011237 | |
| Domain | Metalloenz_LuxS/M16 | 4.34e-04 | 7 | 86 | 2 | IPR011249 | |
| Domain | Peptidase_M16_C | 4.34e-04 | 7 | 86 | 2 | PF05193 | |
| Domain | Pept_M16_N | 4.34e-04 | 7 | 86 | 2 | IPR011765 | |
| Domain | Peptidase_M16 | 4.34e-04 | 7 | 86 | 2 | PF00675 | |
| Domain | - | 4.34e-04 | 7 | 86 | 2 | 3.30.830.10 | |
| Domain | Peptidase_M16_C | 4.34e-04 | 7 | 86 | 2 | IPR007863 | |
| Domain | INSULINASE | 4.34e-04 | 7 | 86 | 2 | PS00143 | |
| Pathway | REACTOME_SYNAPTIC_ADHESION_LIKE_MOLECULES | 7.55e-05 | 20 | 59 | 3 | MM15485 | |
| Pathway | REACTOME_SYNAPTIC_ADHESION_LIKE_MOLECULES | 8.78e-05 | 21 | 59 | 3 | M27736 | |
| Pathway | REACTOME_UNBLOCKING_OF_NMDA_RECEPTORS_GLUTAMATE_BINDING_AND_ACTIVATION | 8.78e-05 | 21 | 59 | 3 | M838 | |
| Pathway | REACTOME_UNBLOCKING_OF_NMDA_RECEPTORS_GLUTAMATE_BINDING_AND_ACTIVATION | 1.01e-04 | 22 | 59 | 3 | MM15104 | |
| Pathway | REACTOME_NRCAM_INTERACTIONS | 3.57e-04 | 7 | 59 | 2 | M27378 | |
| Pathway | REACTOME_ACTIVATION_OF_NMDA_RECEPTORS_AND_POSTSYNAPTIC_EVENTS | 4.14e-04 | 35 | 59 | 3 | MM15109 | |
| Pubmed | 1.61e-07 | 5 | 89 | 3 | 24507884 | ||
| Pubmed | PPP2R2A ZNF609 THADA PTPN14 TCF12 DCDC1 EP400 ERC1 SCML1 PCDH19 DLG4 CRYBG3 KANK2 | 5.24e-06 | 1116 | 89 | 13 | 31753913 | |
| Pubmed | 6.48e-06 | 2 | 89 | 2 | 24244166 | ||
| Pubmed | 6.48e-06 | 2 | 89 | 2 | 19104036 | ||
| Pubmed | 6.48e-06 | 2 | 89 | 2 | 31114072 | ||
| Pubmed | 6.48e-06 | 2 | 89 | 2 | 17344405 | ||
| Pubmed | Clustered gene expression changes flank targeted gene loci in knockout mice. | 6.48e-06 | 2 | 89 | 2 | 18074027 | |
| Pubmed | 6.48e-06 | 2 | 89 | 2 | 23946397 | ||
| Pubmed | 7.04e-06 | 103 | 89 | 5 | 10819331 | ||
| Pubmed | An integrated workflow for charting the human interaction proteome: insights into the PP2A system. | 7.73e-06 | 105 | 89 | 5 | 19156129 | |
| Pubmed | 1.01e-05 | 407 | 89 | 8 | 12693553 | ||
| Pubmed | 1.20e-05 | 197 | 89 | 6 | 36604605 | ||
| Pubmed | A brain atlas of synapse protein lifetime across the mouse lifespan. | 1.94e-05 | 3 | 89 | 2 | 36202095 | |
| Pubmed | SynGAP: a synaptic RasGAP that associates with the PSD-95/SAP90 protein family. | 1.94e-05 | 3 | 89 | 2 | 9581761 | |
| Pubmed | 1.94e-05 | 3 | 89 | 2 | 16102737 | ||
| Pubmed | 1.94e-05 | 3 | 89 | 2 | 1849734 | ||
| Pubmed | 1.94e-05 | 3 | 89 | 2 | 15675958 | ||
| Pubmed | 1.94e-05 | 3 | 89 | 2 | 26739330 | ||
| Pubmed | 1.94e-05 | 3 | 89 | 2 | 29183992 | ||
| Pubmed | 1.94e-05 | 3 | 89 | 2 | 32416252 | ||
| Pubmed | MAGUKs are essential, but redundant, in long-term potentiation. | 1.94e-05 | 3 | 89 | 2 | 34244435 | |
| Pubmed | 1.94e-05 | 3 | 89 | 2 | 23486974 | ||
| Pubmed | 1.94e-05 | 3 | 89 | 2 | 36369219 | ||
| Pubmed | 1.94e-05 | 3 | 89 | 2 | 30078578 | ||
| Pubmed | 1.94e-05 | 3 | 89 | 2 | 25780553 | ||
| Pubmed | 1.94e-05 | 3 | 89 | 2 | 17046693 | ||
| Pubmed | 1.94e-05 | 3 | 89 | 2 | 9514514 | ||
| Pubmed | Calcium-permeable AMPA receptors and silent synapses in cocaine-conditioned place preference. | 1.94e-05 | 3 | 89 | 2 | 28077487 | |
| Pubmed | 1.94e-05 | 3 | 89 | 2 | 10026200 | ||
| Pubmed | Acefylline activates filaggrin deimination by peptidylarginine deiminases in the upper epidermis. | 1.94e-05 | 3 | 89 | 2 | 26616205 | |
| Pubmed | 1.94e-05 | 3 | 89 | 2 | 27886459 | ||
| Pubmed | 2.08e-05 | 21 | 89 | 3 | 18591388 | ||
| Pubmed | Underlying genetic models of inheritance in established type 2 diabetes associations. | 2.08e-05 | 21 | 89 | 3 | 19602701 | |
| Pubmed | PTPN14 is required for the density-dependent control of YAP1. | 2.08e-05 | 21 | 89 | 3 | 22948661 | |
| Pubmed | Mammalian APE1 controls miRNA processing and its interactome is linked to cancer RNA metabolism. | PPP4R1 THADA MYO9A ERC1 DOCK9 TRAPPC10 LAMC3 ZNF79 ZMYM1 TBC1D17 ZC3HAV1 | 2.45e-05 | 925 | 89 | 11 | 28986522 |
| Pubmed | 2.53e-05 | 335 | 89 | 7 | 15741177 | ||
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | FLG PPP2R2A ZNF609 THADA PTPN14 ERC1 GDAP2 SCML1 TRAPPC10 VSIG8 UQCRC2 BBS12 ZC3HAV1 | 3.11e-05 | 1321 | 89 | 13 | 27173435 |
| Pubmed | 3.15e-05 | 24 | 89 | 3 | 22632720 | ||
| Pubmed | 3.58e-05 | 25 | 89 | 3 | 32266943 | ||
| Pubmed | KANK deficiency leads to podocyte dysfunction and nephrotic syndrome. | 3.87e-05 | 4 | 89 | 2 | 25961457 | |
| Pubmed | 3.87e-05 | 4 | 89 | 2 | 19554261 | ||
| Pubmed | Kank proteins: a new family of ankyrin-repeat domain-containing proteins. | 3.87e-05 | 4 | 89 | 2 | 17996375 | |
| Pubmed | X-exome sequencing of 405 unresolved families identifies seven novel intellectual disability genes. | 3.87e-05 | 4 | 89 | 2 | 25644381 | |
| Pubmed | 3.87e-05 | 4 | 89 | 2 | 12576483 | ||
| Pubmed | Cypin: a cytosolic regulator of PSD-95 postsynaptic targeting. | 3.87e-05 | 4 | 89 | 2 | 10595517 | |
| Pubmed | Expression pattern of membrane-associated guanylate kinases in interneurons of the visual cortex. | 3.87e-05 | 4 | 89 | 2 | 21031555 | |
| Pubmed | Synaptic scaffold evolution generated components of vertebrate cognitive complexity. | 3.87e-05 | 4 | 89 | 2 | 23201973 | |
| Pubmed | 3.87e-05 | 4 | 89 | 2 | 31295463 | ||
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | WWC2 PPP2R2A PTPN14 UBR4 DLG4 IDE UQCRC2 SIX4 PPEF1 KANK2 ZC3HAV1 | 3.92e-05 | 974 | 89 | 11 | 28675297 |
| Pubmed | Redundant functions of RIM1alpha and RIM2alpha in Ca(2+)-triggered neurotransmitter release. | 4.04e-05 | 26 | 89 | 3 | 17124501 | |
| Pubmed | 4.53e-05 | 27 | 89 | 3 | 20490451 | ||
| Pubmed | Obesity and diabetes genetic variants associated with gestational weight gain. | 5.64e-05 | 29 | 89 | 3 | 20816152 | |
| Pubmed | Sema4c, a transmembrane semaphorin, interacts with a post-synaptic density protein, PSD-95. | 6.44e-05 | 5 | 89 | 2 | 11134026 | |
| Pubmed | Phase Separation-Mediated TARP/MAGUK Complex Condensation and AMPA Receptor Synaptic Transmission. | 6.44e-05 | 5 | 89 | 2 | 31492534 | |
| Pubmed | 6.44e-05 | 5 | 89 | 2 | 12713445 | ||
| Pubmed | 6.44e-05 | 5 | 89 | 2 | 15578586 | ||
| Pubmed | The neuregulin receptor ErbB-4 interacts with PDZ-containing proteins at neuronal synapses. | 6.44e-05 | 5 | 89 | 2 | 10725395 | |
| Pubmed | 6.44e-05 | 5 | 89 | 2 | 26352593 | ||
| Pubmed | 6.44e-05 | 5 | 89 | 2 | 17529992 | ||
| Pubmed | SAP90 binds and clusters kainate receptors causing incomplete desensitization. | 6.44e-05 | 5 | 89 | 2 | 9808460 | |
| Pubmed | Insulin receptor substrate of 53 kDa links postsynaptic shank to PSD-95. | 6.44e-05 | 5 | 89 | 2 | 15255944 | |
| Pubmed | PPP4R1 WWC2 PPP2R2A ZNF609 PTPN14 ERC1 IDE UQCRC2 CRYBG3 SIX4 PPEF1 | 7.61e-05 | 1049 | 89 | 11 | 27880917 | |
| Pubmed | NMDA receptor trafficking through an interaction between PDZ proteins and the exocyst complex. | 9.65e-05 | 6 | 89 | 2 | 12738960 | |
| Pubmed | 9.65e-05 | 6 | 89 | 2 | 31142747 | ||
| Pubmed | 9.65e-05 | 6 | 89 | 2 | 11572861 | ||
| Pubmed | 9.65e-05 | 6 | 89 | 2 | 11274188 | ||
| Pubmed | PSD-95 is post-transcriptionally repressed during early neural development by PTBP1 and PTBP2. | 9.65e-05 | 6 | 89 | 2 | 22246437 | |
| Pubmed | 9.65e-05 | 6 | 89 | 2 | 14529713 | ||
| Pubmed | 9.65e-05 | 6 | 89 | 2 | 19118189 | ||
| Pubmed | 9.65e-05 | 6 | 89 | 2 | 28973854 | ||
| Pubmed | Epilepsy-related ligand/receptor complex LGI1 and ADAM22 regulate synaptic transmission. | 9.65e-05 | 6 | 89 | 2 | 16990550 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | THADA HEG1 EP400 DOCK9 UBR4 NAV2 LAMC3 GPC2 MYRF TBC1D17 FANCA | 1.20e-04 | 1105 | 89 | 11 | 35748872 |
| Pubmed | 1.28e-04 | 38 | 89 | 3 | 22952603 | ||
| Pubmed | HSF1 transcriptional activity is modulated by IER5 and PP2A/B55. | 1.35e-04 | 7 | 89 | 2 | 25816751 | |
| Pubmed | CKAMP44: a brain-specific protein attenuating short-term synaptic plasticity in the dentate gyrus. | 1.35e-04 | 7 | 89 | 2 | 20185686 | |
| Pubmed | Hippocampal AMPA receptor assemblies and mechanism of allosteric inhibition. | 1.35e-04 | 7 | 89 | 2 | 33981040 | |
| Pubmed | 1.35e-04 | 7 | 89 | 2 | 19243221 | ||
| Pubmed | 1.35e-04 | 7 | 89 | 2 | 17093100 | ||
| Pubmed | Inward rectifier K+ channel Kir2.3 is localized at the postsynaptic membrane of excitatory synapses. | 1.35e-04 | 7 | 89 | 2 | 11997254 | |
| Pubmed | SAPAPs. A family of PSD-95/SAP90-associated proteins localized at postsynaptic density. | 1.35e-04 | 7 | 89 | 2 | 9115257 | |
| Pubmed | Munc13 supports fusogenicity of non-docked vesicles at synapses with disrupted active zones. | 1.35e-04 | 7 | 89 | 2 | 36398873 | |
| Pubmed | A novel family of adhesion-like molecules that interacts with the NMDA receptor. | 1.35e-04 | 7 | 89 | 2 | 16495444 | |
| Pubmed | Polarity protein complex Scribble/Lgl/Dlg and epithelial cell barriers. | 1.79e-04 | 8 | 89 | 2 | 23397623 | |
| Pubmed | The G protein-coupled receptor CL1 interacts directly with proteins of the Shank family. | 1.79e-04 | 8 | 89 | 2 | 10958799 | |
| Pubmed | The serotonin 5-HT2A and 5-HT2C receptors interact with specific sets of PDZ proteins. | 1.79e-04 | 8 | 89 | 2 | 14988405 | |
| Pubmed | 1.79e-04 | 8 | 89 | 2 | 11956189 | ||
| Pubmed | 1.79e-04 | 8 | 89 | 2 | 37261953 | ||
| Pubmed | 1.79e-04 | 8 | 89 | 2 | 15638722 | ||
| Pubmed | 1.79e-04 | 8 | 89 | 2 | 17245430 | ||
| Pubmed | 2.06e-04 | 209 | 89 | 5 | 36779422 | ||
| Pubmed | 2.14e-04 | 472 | 89 | 7 | 38943005 | ||
| Pubmed | 2.16e-04 | 114 | 89 | 4 | 21150319 | ||
| Pubmed | 2.30e-04 | 9 | 89 | 2 | 18432318 | ||
| Pubmed | Loss of postsynaptic GABA(A) receptor clustering in gephyrin-deficient mice. | 2.30e-04 | 9 | 89 | 2 | 10531433 | |
| Pubmed | 2.30e-04 | 9 | 89 | 2 | 17526495 | ||
| Pubmed | 2.30e-04 | 9 | 89 | 2 | 19762425 | ||
| Pubmed | 2.30e-04 | 9 | 89 | 2 | 9278515 | ||
| Pubmed | 2.30e-04 | 9 | 89 | 2 | 17938206 | ||
| Pubmed | 2.35e-04 | 638 | 89 | 8 | 31182584 | ||
| Pubmed | 2.67e-04 | 650 | 89 | 8 | 38777146 | ||
| GeneFamily | Ankyrin repeat domain containing|KN motif and ankyrin repeat domain containing | 7.84e-05 | 4 | 66 | 2 | 623 | |
| GeneFamily | WD repeat domain containing|Protein phosphatase 2 regulatory subunits | 1.34e-03 | 15 | 66 | 2 | 696 | |
| ToppCell | Bronchial-NucSeq|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations | 5.87e-09 | 196 | 89 | 8 | ab53c742866945545a92e2e61850d63c80d9a2a6 | |
| ToppCell | Parenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations | 6.36e-09 | 198 | 89 | 8 | 1996373bdccc55aac347d349bd22f6aad6d0c668 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_only / Treatment groups by lineage, cell group, cell type | 6.88e-09 | 200 | 89 | 8 | 2dadf317a42a7e27cc1fac74f91b806c93a57108 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.72e-06 | 181 | 89 | 6 | b45b11428d13950369347e051d4d517efb2bd4fd | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.01e-06 | 186 | 89 | 6 | 3aebe163799109ffc67e4e10ee47c2dd0886a92c | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.08e-06 | 187 | 89 | 6 | 58d48128547ee3513d0bf7f78e61b76b1c472ca9 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference|renal_medulla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 2.28e-06 | 190 | 89 | 6 | f1363f7806cfc4f14fbc1b0e8dac2de813a88eee | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.97e-06 | 199 | 89 | 6 | 333056c2abe9724efeab542c0365fcfe4eff8f18 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.97e-06 | 199 | 89 | 6 | d43c605a4ff221cf78d91678c15d2ad20f831c7f | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.97e-06 | 199 | 89 | 6 | 19a97e27a4758e794ce7246d295e112b47931a48 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.97e-06 | 199 | 89 | 6 | e60ecbb8fa7bcd3e2ce7d78f6efb2cfd1fd77698 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.06e-06 | 200 | 89 | 6 | 8683445ad5b70748c4a1f12eb77d47623085147e | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Oligoastrocytoma-3|TCGA-Brain / Sample_Type by Project: Shred V9 | 7.66e-06 | 135 | 89 | 5 | 3351e8b9e417397c5fa9f856184ff24ce1a27242 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Astrocytoma-3|TCGA-Brain / Sample_Type by Project: Shred V9 | 1.24e-05 | 149 | 89 | 5 | 768877bade04ca0321593b8470b5011ad8270431 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-stromal_related|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.80e-05 | 161 | 89 | 5 | 8aaca49b53a551395f4025ac4e535c7b0ce41a49 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-stromal_related-ICC|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.80e-05 | 161 | 89 | 5 | deb10628d258fb813c293f81fb71be8e383dc82a | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-mesothelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.14e-05 | 167 | 89 | 5 | 743df5908c1ceb43b34b240d9f9649f30f4142fa | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-mesothelial_cell-mesothelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.14e-05 | 167 | 89 | 5 | 1adb566f98af0109c8cc6e36033b89651e2c75e7 | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.47e-05 | 172 | 89 | 5 | 7fb31ccbcd0204c3612986a6bc20d57ed6825e9c | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-CD4+_macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.47e-05 | 172 | 89 | 5 | 2a4614b3d25e8c6b095e6992d8ca35371dcdb5e1 | |
| ToppCell | Control-Epithelial_alveolar-AT_1-Differentiating_AT1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.83e-05 | 177 | 89 | 5 | 9af14a056eb6d88c6f11b09f6d4c0d3448d647d5 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-6_VIP_VIP|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.99e-05 | 179 | 89 | 5 | cd7f0e8f4abb2a2bac366c8910c8c5fda841dbce | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.15e-05 | 181 | 89 | 5 | 576da14ab3107f89e1f44a4a439d1bef5bb42370 | |
| ToppCell | 3'-Adult-SmallIntestine-Endothelial-blood_vessel_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.32e-05 | 183 | 89 | 5 | 858682df5592c6856487487a7baabd6e60e63a38 | |
| ToppCell | 3'-Adult-SmallIntestine-Endothelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.32e-05 | 183 | 89 | 5 | f8212bf8a8b8312434ae030261c558c147f61747 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.32e-05 | 183 | 89 | 5 | ff6dde877659cde9daa3263db0932c9c9ef1adac | |
| ToppCell | AT1-AT2_cells-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 3.32e-05 | 183 | 89 | 5 | 6821dca076318115d360ff426eb1218cfe104063 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT1-AT1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.40e-05 | 184 | 89 | 5 | 57c792e6e2fedba25d3350ffe649fd74750b579d | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-AT2_Progenitor|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.40e-05 | 184 | 89 | 5 | 7cc5796557379c3d1db078c1aeda40659c6e401c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.40e-05 | 184 | 89 | 5 | 7294b379ce4cb8fa75e432559082f93cd106aaf5 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.40e-05 | 184 | 89 | 5 | d7bd0f0c607bade67c99e9fb3578a570298bf926 | |
| ToppCell | Control-Epithelial_alveolar|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.49e-05 | 185 | 89 | 5 | 3937e026add96a396122139daf8011cfbc60e75c | |
| ToppCell | droplet-Tongue-nan-24m-Epithelial-parabasal|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.59e-05 | 186 | 89 | 5 | 18c06041c6c8a0ebac17b3c8aaebd67e652d315a | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T2|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 3.68e-05 | 187 | 89 | 5 | f3e37c18ac6471c7992609bbddfa4975571c815c | |
| ToppCell | wk_15-18-Epithelial-PNS-PCP4+_neuron|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 3.87e-05 | 189 | 89 | 5 | 22c927d2691b867fbdee1fbee042a6d3f7eadd7d | |
| ToppCell | renal_medulla_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 3.87e-05 | 189 | 89 | 5 | 830d9cd0dd706bce22eb2416f07b2c31c870a05a | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.97e-05 | 190 | 89 | 5 | 3fc9e18c7441c0ae8cda65753cc42d0520f4e116 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.97e-05 | 190 | 89 | 5 | 30b50d183d7649146eb1e79b47ba897355f1998a | |
| ToppCell | LAM-Epithelial-AT1|Epithelial / Condition, Lineage and Cell class | 4.07e-05 | 191 | 89 | 5 | 3457e15d1e9b36a78363d46b320c4ec46b40290a | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_GGH|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.07e-05 | 191 | 89 | 5 | 06760c3bb40e4f66879a5f5e09c9abfce4ebbba3 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.07e-05 | 191 | 89 | 5 | 5a67ff17fb4b9eff641176dff07830c9cd73754e | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.07e-05 | 191 | 89 | 5 | 55ab2854a02cdcfc395e49870ccb7290b5e5471d | |
| ToppCell | facs-Skin-Anagen-3m-Epithelial-bulge_keratinocyte|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.27e-05 | 193 | 89 | 5 | eba3c70701b051bc1ed1f4db9270cb27a77ffc3e | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.38e-05 | 194 | 89 | 5 | 0b9cd96fa0b616da7cc90e92ff71157e9bba518f | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.49e-05 | 195 | 89 | 5 | 6477e6e7be5bd8eb99119a12ae16334ccddecd43 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.60e-05 | 196 | 89 | 5 | eea66711a16134f86e6c533a5a837ff2e0d7ca7f | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_1-Differentiating_AT1|Control_saline / Treatment groups by lineage, cell group, cell type | 4.83e-05 | 198 | 89 | 5 | 85f424cd9bb3117c9e322031024aabb87696ce47 | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 4.83e-05 | 198 | 89 | 5 | b598ab958e31f1e98bd06dc0097b58ac3a3f90a3 | |
| ToppCell | wk_08-11-Epithelial-PNS-TM4SF4+_CHODL+_neuron|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 4.83e-05 | 198 | 89 | 5 | eb3c389e7452d74e5e15179503e480d6d11ca9ca | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 4.94e-05 | 199 | 89 | 5 | a270630626df614f8605abddb7dee7c4d74f6149 | |
| ToppCell | Tracheal-NucSeq-Stromal-Peri/Epineurial_-NAF_epineurial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.94e-05 | 199 | 89 | 5 | 9c2db0bb94cba71a3cc1827844da090e213e0258 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 5.06e-05 | 200 | 89 | 5 | ddfb1f006365bf16203ee49f20200f68220cc288 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_3-GGH-L1-3|Neuronal / cells hierarchy compared to all cells using T-Statistic | 5.06e-05 | 200 | 89 | 5 | 48303e499251d6754cfa991dc2d96c5563b2123c | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_3-GGH|Neuronal / cells hierarchy compared to all cells using T-Statistic | 5.06e-05 | 200 | 89 | 5 | 4802dd6cae84b41746227a5d1aa1c9b858495e36 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.34e-04 | 130 | 89 | 4 | 6434d9106ccb38786dad36fab80163dfc07b6eb7 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_3|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.47e-04 | 133 | 89 | 4 | f303ab771482281d8793974f9f5279cee09431fe | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Oligodendroglioma-3|TCGA-Brain / Sample_Type by Project: Shred V9 | 1.55e-04 | 135 | 89 | 4 | b128596653a5e3b64ed7f657bbfeda35438e2e48 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.21e-04 | 148 | 89 | 4 | d6ac5972267254651dfbe16bb4e9a62228093cc7 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.33e-04 | 150 | 89 | 4 | 322aa0c3fc159a4b2897daac881dfc744b24ffc4 | |
| ToppCell | LPS_only-Lymphocytic_NKT-iNKT/MAIT-T-cells|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.39e-04 | 151 | 89 | 4 | 7270b8bbfae659e110bd9d513b602120b25de3dd | |
| ToppCell | droplet-Liver-Npc-21m-Myeloid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.57e-04 | 154 | 89 | 4 | d883b3e2a65e4375bea1216eb9bbc86c64ee449c | |
| ToppCell | droplet-Liver-Npc-21m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.63e-04 | 155 | 89 | 4 | 5d600e159738231d0607ea1a1ebd8510fc241b36 | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.63e-04 | 155 | 89 | 4 | 8fdda4e3657ac56188ae88ed3caf145f4d9d1567 | |
| ToppCell | 356C-Myeloid-Dendritic-pDC|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.70e-04 | 156 | 89 | 4 | d9d87368e43b24952e70f31f38425e15b716ff5b | |
| ToppCell | severe_influenza-CD8+_T_naive|World / disease group, cell group and cell class (v2) | 2.97e-04 | 160 | 89 | 4 | a1181ef36b453eba53b04d836aa9f65a71354cdb | |
| ToppCell | 356C-Fibroblasts-Fibroblast-G-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 2.97e-04 | 160 | 89 | 4 | 0293b244c063a62819690bf22bbc2681f8d15252 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-G|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 2.97e-04 | 160 | 89 | 4 | 3eaae86fa08f7651021316f8e5811bf48055591e | |
| ToppCell | normal_Lung-Myeloid_cells-Undetermined|Myeloid_cells / Location, Cell class and cell subclass | 3.04e-04 | 161 | 89 | 4 | 283012858e575c70d09950de53da041509f59bfa | |
| ToppCell | severe_influenza-CD8+_T_naive|severe_influenza / disease group, cell group and cell class (v2) | 3.04e-04 | 161 | 89 | 4 | 82196139cdbbd70a36957a87bc9ac6d02575da3f | |
| ToppCell | E16.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.12e-04 | 162 | 89 | 4 | 8e0f03fcc25b2ea777e8478fbf771699cf93719c | |
| ToppCell | E16.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.12e-04 | 162 | 89 | 4 | e0417f1242edf71934fe62bccc55c4678f7ff4ac | |
| ToppCell | P15-Mesenchymal-mesenchymal_fibroblast-mesothelial_cell_of_visceral_pleura|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.42e-04 | 166 | 89 | 4 | 545f6c91102568791443717e522f89cb3bd1a070 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.42e-04 | 166 | 89 | 4 | 8e5f2afbeffae5e77fcb29e8fe9f5aa49779b619 | |
| ToppCell | Cerebellum-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 3.50e-04 | 167 | 89 | 4 | 9efb9511a211d0824bb97f82c1a5860c43d2138f | |
| ToppCell | Cerebellum-Neuronal-Inhibitory|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 3.50e-04 | 167 | 89 | 4 | 904c613aac3f9919a432b110bb1dcc832b5aec0a | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.66e-04 | 169 | 89 | 4 | 987ff79ad563825dd9877ea8ccb536758f8c6700 | |
| ToppCell | PND07-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2-CAP2_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.66e-04 | 169 | 89 | 4 | 8a6d05b5d60b2b2e43a8ff7521feb79cd6dbd940 | |
| ToppCell | Control-Epithelial_cells-ECM-high_epithelial|Control / group, cell type (main and fine annotations) | 3.74e-04 | 170 | 89 | 4 | e2023d66e70983c87dacbd6181d3426488d1fc57 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.82e-04 | 171 | 89 | 4 | c2dbc439af28d4fabb24d57685b75b2e588819b0 | |
| ToppCell | droplet-Pancreas-Exocrine|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.82e-04 | 171 | 89 | 4 | 92ac4cc3d54da2ea8e202aa59c78e8875356649e | |
| ToppCell | COVID-19-Heart-T_cell|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.82e-04 | 171 | 89 | 4 | b2e753e811a7639956994609f73efcdb62d04f82 | |
| ToppCell | E12.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_immature_unknown_1|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.91e-04 | 172 | 89 | 4 | 3b9be685fcd1634498a603b692f5ac6ddd0de176 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.00e-04 | 173 | 89 | 4 | ee7d1429f23f1b89a9a9f7bc07a84a44cf7acd1c | |
| ToppCell | AT1_cells-Donor_03|World / lung cells shred on cell class, cell subclass, sample id | 4.00e-04 | 173 | 89 | 4 | 3afca2a429c634af0220c1aa19ce4cf4ee3e8b3e | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.00e-04 | 173 | 89 | 4 | 3725525b99a6011eda2ff5459b4fd2e1eab1f090 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Neuronal-Glial_immature-Glia_1_(DHH+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.00e-04 | 173 | 89 | 4 | 922356a5b4c84607318ac24d7caa2e235b72b066 | |
| ToppCell | facs-Lung-24m-Mesenchymal-myofibroblast-myofibroblast_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.08e-04 | 174 | 89 | 4 | eb8012823b08729b462d1e5212f4873bb6b4eb1e | |
| ToppCell | Control-Epithelial_cells-AT1|Control / group, cell type (main and fine annotations) | 4.08e-04 | 174 | 89 | 4 | 548d7f2b958a2bfd2c95eb049ceaab55a559c77d | |
| ToppCell | facs-Lung-24m-Mesenchymal-myofibroblast-myofibroblast_cell-pulmonary_interstitial_myofibroblast|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.08e-04 | 174 | 89 | 4 | 32fdeeebeeeca657eac6329caad4c28ca54e4d1c | |
| ToppCell | PND03-Epithelial-Epithelial_Airway-Neurosecretory-PNEC-PNEC_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.17e-04 | 175 | 89 | 4 | 8362a46f5804333baa84cd56d450bc147f372a7e | |
| ToppCell | TCGA-Cervix-Primary_Tumor-Cervical_Carcinoma-Non-keratinizing_Cervical_Squamous_Cell_Carcinoma-3|TCGA-Cervix / Sample_Type by Project: Shred V9 | 4.17e-04 | 175 | 89 | 4 | 0cc215109d9915af47e4d0a120ce2e46910715fa | |
| ToppCell | PND03-Epithelial-Epithelial_Airway-Neurosecretory-PNEC|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.17e-04 | 175 | 89 | 4 | 8b4c62e608f0ec84e563bbf0ebffe3ed44085298 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_ZNF322P1|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.17e-04 | 175 | 89 | 4 | 9d09636a103daa8f622c3dbfd1f1536aaec3b6bb | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Neuronal-neurons_B-Branch_B3_(IPAN)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.26e-04 | 176 | 89 | 4 | 04dad262929581872e5bbc66cd8182c963e7e52f | |
| ToppCell | 3'-Adult-Appendix-Epithelial-mature_enterocytic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.26e-04 | 176 | 89 | 4 | 30adf8f1638c6244586f8101c2590bb964dfae00 | |
| ToppCell | 3'-Adult-Appendix-Epithelial-mature_enterocytic-Colonocyte|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.26e-04 | 176 | 89 | 4 | 23fa02d4c39e0b8faa1658116d50b6233a952ccc | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.26e-04 | 176 | 89 | 4 | 327a3e81b724252e36d786de92a3ffd721ea6d7b | |
| ToppCell | facs-Lung-nan-3m-Epithelial-club_cell_of_bronchiole|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.36e-04 | 177 | 89 | 4 | e5070934c674a46e070b0d52b9a374516bf6aea1 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.36e-04 | 177 | 89 | 4 | da8802a6351d3e510822f82e2fde8a4314a2216e | |
| ToppCell | facs-Lung-nan-3m-Epithelial-Club_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.36e-04 | 177 | 89 | 4 | b37d821f4f3204daf7c568ac17a0af0ba97273d6 | |
| Disease | level of Phosphatidylcholine (18:2_20:4) in blood serum | 1.67e-04 | 7 | 84 | 2 | OBA_2045109 | |
| Disease | benign neoplasm (implicated_via_orthology) | 2.22e-04 | 8 | 84 | 2 | DOID:0060072 (implicated_via_orthology) | |
| Disease | primary ovarian insufficiency | 2.85e-04 | 9 | 84 | 2 | EFO_0004266 | |
| Disease | non-syndromic X-linked intellectual disability (implicated_via_orthology) | 2.85e-04 | 9 | 84 | 2 | DOID:0050776 (implicated_via_orthology) | |
| Disease | cytokine measurement | 3.49e-04 | 461 | 84 | 7 | EFO_0004873 | |
| Disease | developmental disorder of mental health (implicated_via_orthology) | 3.73e-04 | 49 | 84 | 3 | DOID:0060037 (implicated_via_orthology) | |
| Disease | autosomal dominant cerebellar ataxia (implicated_via_orthology) | 5.19e-04 | 12 | 84 | 2 | DOID:1441 (implicated_via_orthology) | |
| Disease | stenosing tenosynovitis | 5.19e-04 | 12 | 84 | 2 | EFO_0010822 | |
| Disease | low density lipoprotein cholesterol measurement, response to selective serotonin reuptake inhibitor | 8.21e-04 | 15 | 84 | 2 | EFO_0004611, EFO_0005658 | |
| Disease | phosphatidylcholine 38:3 measurement | 9.36e-04 | 16 | 84 | 2 | EFO_0010385 | |
| Disease | nucleotide measurement | 1.20e-03 | 73 | 84 | 3 | EFO_0010513 | |
| Disease | Arthrogryposis | 1.62e-03 | 21 | 84 | 2 | C0003886 | |
| Disease | response to xenobiotic stimulus | 1.84e-03 | 182 | 84 | 4 | GO_0009410 | |
| Disease | Autism Spectrum Disorders | 1.86e-03 | 85 | 84 | 3 | C1510586 | |
| Disease | thalamus volume | 1.86e-03 | 85 | 84 | 3 | EFO_0006935 | |
| Disease | alpha-linolenic acid measurement | 2.30e-03 | 25 | 84 | 2 | EFO_0007759 | |
| Disease | Bipolar Disorder | 2.43e-03 | 477 | 84 | 6 | C0005586 | |
| Disease | cholesteryl ester measurement, intermediate density lipoprotein measurement | 2.48e-03 | 94 | 84 | 3 | EFO_0008595, EFO_0010351 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| QDENATHTQLYTSHF | 2451 | Q96L91 | |
| AHTYHINSISVNSDY | 171 | Q00005 | |
| SINDSFYTSHLHVSL | 266 | Q8TD16 | |
| SHETTVYFHSDHSQN | 2051 | Q7Z408 | |
| AYHQYLQTSQSHSSE | 2236 | Q68DQ2 | |
| HTYHINSISINSDYE | 176 | P63151 | |
| QTHHSSEDYNLSTAL | 146 | Q6ZNB7 | |
| FLYQVSSHEQSESTH | 1441 | P20930 | |
| HEQAQDSSRHSASQY | 3091 | P20930 | |
| FLYQVSTHEQSESAH | 3386 | P20930 | |
| FQNTVSDLSELHHAY | 981 | Q96M86 | |
| LSSNLQHHFSLSSVY | 441 | Q5VTE6 | |
| SEFEASTYIQHHLQN | 611 | Q6ZW61 | |
| SASEFASHHYNLNIL | 351 | Q8N7E2 | |
| ASDFHLQEHSNSNSY | 2471 | Q9Y485 | |
| FHSDHRLSYSSQEEF | 21 | Q9UKP5 | |
| DFQKILDTYSQHHTS | 451 | Q96QP1 | |
| NYEDDHFKSSHSNQT | 986 | Q8IUD2 | |
| HLDYNFHRSSINSLS | 466 | Q8TBY0 | |
| TSEELHYFVQNHFTS | 201 | P22695 | |
| SHQQLSASSHTDYAS | 296 | Q9Y257 | |
| TDANHTTSFHSSEVY | 2946 | Q01484 | |
| ADLDYSADHSNLSFS | 286 | Q96SQ7 | |
| RNTSANHIYHHSFNS | 841 | Q8TAB3 | |
| FHTLTSEYNHLDSDF | 391 | Q9NXN4 | |
| HSHDEISDLDSYKSN | 106 | M0R2J8 | |
| SDQVLHSKQSHFYET | 1571 | Q5T1H1 | |
| EYSHNSFDLHCLLNS | 6 | Q8IV33 | |
| SVAQHSLTQLFSHSY | 116 | Q8N158 | |
| LNYHVDHLDSSNSFS | 71 | P42263 | |
| SVNKQHYESGAASFH | 71 | Q8NBM8 | |
| LSNGFSHYSLSSESH | 346 | O43312 | |
| AYHNSLHAADVAQST | 386 | Q08493 | |
| SNAYHNSTHAADVLH | 611 | O95263 | |
| NSSAHYHVNFSQAIS | 296 | Q9Y4A8 | |
| FTDSPHYSDHLNDSR | 76 | Q99081 | |
| NGNTALHYSVSHSNF | 1161 | Q14678 | |
| HNNFYRADSDSADSA | 321 | P54753 | |
| SNSSHSEYSSFFHAQ | 591 | Q9ULI3 | |
| DLNDSHVQISYHSSH | 86 | Q9ULW8 | |
| SHSSKHVSQYTFVDN | 251 | Q7Z6W7 | |
| NSLTFNHSYGHSDAD | 1371 | Q9BZ29 | |
| HSNHLQYVSFKVDSS | 106 | Q9UKT7 | |
| SELHSFHQSQQHYST | 266 | Q8N5C1 | |
| FHQSSRSYDHSENSD | 991 | O15360 | |
| LAQYSDEFHSEFHLS | 71 | A8TX70 | |
| YSSGHVHLSSENKFQ | 66 | P01031 | |
| YASTFTALADNHISH | 326 | Q92796 | |
| TTSYSQHLDNEISHS | 261 | P78352 | |
| NGNTALHYSVSHANF | 666 | Q63ZY3 | |
| EYSQFLSEHAGSSNA | 126 | P14735 | |
| DESHYFTSSSLKQHL | 821 | P42658 | |
| HNFNTYSDDISDSLN | 186 | Q16820 | |
| KLFSSHYNVHIDDSQ | 596 | O14829 | |
| ADSIHNTYSTDHASA | 216 | Q9UN30 | |
| AYSDSKHGTNSDFQH | 1416 | Q6YHU6 | |
| LTSSHAYDNFLEHSN | 386 | O75674 | |
| STLHYIHSDSDLSNN | 586 | Q8TF05 | |
| YDSDSNSNSHHDDIL | 2466 | Q8IVL1 | |
| EHYSETHTSQDSIFH | 346 | Q15678 | |
| YSILESHSFESANHP | 166 | Q9UIU6 | |
| AYNSFLNHSDSESDV | 1216 | Q5VXU9 | |
| KTDASFHAYDSHTNT | 81 | Q13621 | |
| SSALSNSFHHLQLFD | 191 | Q9HA65 | |
| AFSDLSSFQNHETTH | 451 | P16415 | |
| TSQHSYHSELSYQES | 196 | P0DPA2 | |
| SSSHDASLHQFTADF | 571 | Q6AWC2 | |
| HFTLNYTSHAHELSA | 101 | Q96N35 | |
| SHYSDSQLSLHEDLS | 641 | Q8NB66 | |
| SAHYSYDHQTEELNL | 231 | P23942 | |
| SDQSYHTHLLSTNTA | 986 | O15014 | |
| DKNSFFHYDSHSRSN | 111 | Q96LD8 | |
| FNSYAHLSHSQDIKS | 1296 | Q9UGU0 | |
| YSINKHSSNFSRDAH | 266 | Q8N841 | |
| SICSNNFDSFLHETH | 796 | Q7Z2W4 | |
| HSSNTSFADELSHLL | 836 | Q5SVZ6 | |
| KSFYTESNLHQHLAS | 1451 | Q9C0G0 | |
| ENYLQTSSLLASDHH | 536 | P48553 | |
| SSDEEFAAALYHFNH | 701 | Q5T4S7 | |
| AFSYCSSLSQHQKSH | 201 | Q15937 | |
| YNSSFISHQRNHTSE | 141 | Q8NCK3 | |
| SQIDSHSSNSNYHDS | 581 | Q5T200 | |
| HSQESGSSVFYHSQD | 596 | Q5TIE3 | |
| SSSHHSLDNADFDNK | 476 | Q9P2D8 | |
| SHSYSSDESLNRQNH | 776 | Q7Z570 | |
| FSYSNSFQLHERTHT | 501 | Q14584 | |
| DSSSSEEFYQAVHHA | 181 | Q9NR64 | |
| HNASYLTDFHSQDES | 86 | Q9Y6N6 | |
| LKSTTESYVFHNHSN | 26 | Q92802 | |
| HFRPTQSYSHNSDDL | 1646 | B2RTY4 | |
| SSEALAQPATDYHFH | 1131 | Q9Y2G1 |